{
    "root": "40bb5ee2-b823-4a41-8f03-1d03539f74be",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Meloxicam"
    },
    "value": "20250315",
    "ingredients": [
        {
            "name": "MELOXICAM",
            "code": "VG2QF83CGL"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K25",
            "code": "K0KQV10C35"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        }
    ],
    "indications": "meloxicam non-steroidal anti-inflammatory indicated : osteoarthritis ( oa ) ( 1.1 ) rheumatoid arthritis ( rheumatoid arthritis ) ( 1.2 ) juvenile rheumatoid arthritis ( jra ) patients weigh \u226560 kg ( 1.3 )",
    "contraindications": "lowest effective shortest duration consistent individual patient treatment goals ( 2.1 ) oa ( 2.2 ) rheumatoid arthritis ( 2.3 ) : starting dose : 7.5 mg daily dose may increased 15 mg daily jra ( 2.4 ) : 7.5 mg daily children \u226560 kg meloxicam tablets interchangeable approved formulations oral meloxicam even total milligram strength ( 2.6 )",
    "warningsAndPrecautions": "meloxicam tablets usp , 7.5 mg pastel yellow , round , biconvex , uncoated tablet debossed \u2018 c \u2019 one side \u2018 79 \u2019 side , supplied follows : bottles 100 ndc 65862-097-01 bottles 500 ndc 65862-097-05 bottles 1,000 ndc 65862-097-99 meloxicam tablets usp , 15 mg pastel yellow , oblong , biconvex , uncoated tablet debossed \u2018 c \u2019 one side \u2018 80 \u2019 side , supplied follows : bottles 100 ndc 65862-098-01 bottles 500 ndc 65862-098-05 bottles 1,000 ndc 65862-098-99 storage store 20 25oc ( 68 77of ) [ usp controlled room temperature ] . protect moisture . keep dry place . dispense tablets tight container . keep medications reach children .",
    "adverseReactions": "meloxicam tablets contraindicated following patients : known hypersensitivity ( e.g . , anaphylactic serious skin ) meloxicam components product [ ( 5.7 , 5.9 ) ] history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ]",
    "indications_original": "Meloxicam is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh \u226560 kg ( 1.3 )",
    "contraindications_original": "Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( 2.1 ) OA ( 2.2 ) and RA ( 2.3 ): Starting dose: 7.5 mg once daily Dose may be increased to 15 mg once daily JRA ( 2.4 ): 7.5 mg once daily in children \u226560 kg Meloxicam tablets are not interchangeable with approved formulations of oral meloxicam even if the total milligram strength is the same ( 2.6 )",
    "warningsAndPrecautions_original": "Meloxicam Tablets USP, 7.5 mg are pastel yellow, round, biconvex, uncoated tablet debossed with \u2018C\u2019 on one side and \u201879\u2019 on the other side, and is supplied as follows:\n                      \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 100\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 65862-097-01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 500\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 65862-097-05\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 1,000\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 65862-097-99\n                     \n                         Meloxicam Tablets USP, 15 mg are pastel yellow, oblong, biconvex, uncoated tablet debossed with \u2018C\u2019 on one side and \u201880\u2019 on the other side, and is supplied as follows:\n                      \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 100\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 65862-098-01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 500\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 65862-098-05\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 1,000\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 65862-098-99\n                     \n                         Storage\n                     \n                     \n                         Store at 20 to 25oC (68 to 77oF) [See USP Controlled Room Temperature]. Protect from moisture. Keep in a dry place.\n                      Dispense tablets in a tight container.\n                      Keep this and all medications out of the reach of children.",
    "adverseReactions_original": "Meloxicam tablets are contraindicated in the following patients: \n                  \n                     Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see Warnings and Precautions (5.7, 5.9)]\n                     \n                     History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.7, 5.8)]\n                     \n                     In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.1)]"
}